Excessive Daytime Sleepiness Epidemiology Forecast till 2030

July 22 19:46 2020
Excessive Daytime Sleepiness Epidemiology Forecast till 2030

DelveInsight Business Research LLP
DelveInsight’s ‘Excessive Daytime Sleepiness Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Excessive Daytime Sleepiness (EDS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Excessive Daytime Sleepiness (EDS) epidemiology report by DelveInsight gives a thorough understanding of the Excessive Daytime Sleepiness (EDS) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Excessive Daytime Sleepiness (EDS) in the US, Europe, and Japan. The report covers the detailed information of the Excessive Daytime Sleepiness (EDS) epidemiology scenario in seven major countries (US, EU5, and Japan).

 

Some of the key facts of the report

1. There are 19.5% of US adults that are suffering from moderate to severe excessive daytime sleepiness.
2. It is estimated that 20–25% of people with narcolepsy have all four symptoms, including excessive daytime sleepiness, abrupt loss of muscle function, sleep paralysis and hallucinations.
3. The prevalence of Excessive Daytime Sleepiness is more in individuals aged between 20 and 49 years.

 

 

 

Scope of the Report

1. The Excessive Daytime Sleepiness (EDS) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

2. The Excessive Daytime Sleepiness (EDS) Epidemiology Report and Model provide an overview of the risk factors and global trends of Excessive Daytime Sleepiness (EDS) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)

3. The report provides insight about the historical and forecasted patient pool of Excessive Daytime Sleepiness (EDS) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

4. The report helps to recognize the growth opportunities in the 7MM with respect to the patient population

5. The report assesses the disease risk and burden and highlights the unmet needs of Excessive Daytime Sleepiness (EDS)

6. The report provides the segmentation of the Excessive Daytime Sleepiness (EDS) epidemiology

 

Table of contents

 

1. Key Insights 

 

2. Executive Summary of Excessive Daytime Sleepiness (EDS)

 

3. Excessive Daytime Sleepiness (EDS): Disease Background and Overview

 

3.1. Introduction

 

3.2. Sign and Symptoms

 

3.3. Pathophysiology

 

3.4. Risk Factors

 

3.5. Diagnosis

 

4. Patient Journey

 

5. Epidemiology and Patient Population

 

5.1. Epidemiology Key Findings

 

5.2. Assumptions and Rationale: 7MM

 

5.3. Epidemiology Scenario: 7MM

 

5.3.1. Excessive Daytime Sleepiness (EDS) Epidemiology Scenario in the 7MM (2017- 2030)

 

5.4. United States Epidemiology

 

5.4.1. Excessive Daytime Sleepiness (EDS) Epidemiology Scenario in the United States (2017- 2030)

 

5.5. EU-5 Country-wise Epidemiology

 

5.5.1. Germany Epidemiology

 

5.5.1.1. Excessive Daytime Sleepiness (EDS) Epidemiology Scenario in Germany (2017- 2030)

 

5.5.2. France Epidemiology

 

5.5.2.1. Excessive Daytime Sleepiness (EDS) Epidemiology Scenario in France (2017- 2030)

 

5.5.3. Italy Epidemiology

 

5.5.3.1. Excessive Daytime Sleepiness (EDS) Epidemiology Scenario in Italy (2017- 2030)

 

5.5.4. Spain Epidemiology

 

5.5.4.1. Excessive Daytime Sleepiness (EDS) Epidemiology Scenario in Spain (2017- 2030)

 

5.5.5. United Kingdom Epidemiology

 

5.5.5.1. Excessive Daytime Sleepiness (EDS) Epidemiology Scenario in the United Kingdom (2017-2030)

 

5.6. Japan Epidemiology

 

5.6.1. Excessive Daytime Sleepiness (EDS) Epidemiology Scenario in Japan (2017- 2030)

 

6. Treatment Algorithm, Current Treatment, and Medical Practices

 

6.1. Excessive Daytime Sleepiness (EDS) Treatment and Management

 

6.2. Excessive Daytime Sleepiness (EDS) Treatment Algorithm

 

7. KOL Views

 

8. Unmet Needs

 

9.  Appendix

 

9.1. Bibliography

 

9.2. Report Methodology

 

10. DelveInsight Capabilities

 

11. Disclaimer

 

12. About DelveInsight

 

 

Scope of the Report

  • The Excessive Daytime Sleepiness (EDS) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Excessive Daytime Sleepiness (EDS) Epidemiology Report and Model provide an overview of the risk factors and global trends of Excessive Daytime Sleepiness (EDS) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Excessive Daytime Sleepiness (EDS) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Excessive Daytime Sleepiness (EDS)
  • The report provides the segmentation of the Excessive Daytime Sleepiness (EDS) epidemiology

 

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/haridwartoday/goaheadlines.org/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7